Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Uniqure NV (NASDAQ:QURE)

7.17
Delayed Data
As of Jul 22
 -0.20 / -2.71%
Today’s Change
6.75
Today|||52-Week Range
36.38
-56.65%
Year-to-Date
No recent news for Uniqure NV.

Today’s Trading

Previous close7.37
Today’s open7.37
Day’s range7.16 - 7.49
Volume134,618
Average volume (3 months)301,966
Market cap$178.0M
Dividend yield--
Data as of 3:59pm ET, 07/22/2016

Growth & Valuation

Earnings growth (last year)-25.40%
Earnings growth (this year)+0.73%
Earnings growth (next 5 years)-26.60%
Revenue growth (last year)+68.18%
P/E ratio--
Price/Sales34.95
Price/Book1.34

Competitors

 Today’s
change
Today’s
% change
PFNXPfenex Inc+0.01+0.13%
OSIROsiris Therapeutics ...-0.08-1.54%
OVASOvaScience Inc-0.05-0.97%
ENZYEnzymotec Ltd+0.36+4.21%
Data as of 4:02pm ET, 07/22/2016

Financials

Next reporting dateAugust 25, 2016
EPS forecast (this quarter)-$0.89
Annual revenue (last year)$10.5M
Annual profit (last year)-$79.3M
Net profit margin-758.41%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Executive Director
Don Soland
Chief Operating Officer
Eric Goossens
Corporate headquarters
Amsterdam, Noord-holland

Forecasts

Partner Offers

Search for Jobs